Tympanosclerosis
(Redirected from Myringosclerosis)
A condition affecting the tympanic membrane and middle ear
Tympanosclerosis is a condition characterized by the calcification and scarring of the tympanic membrane (eardrum) and sometimes the middle ear structures. It is often associated with chronic otitis media and can lead to conductive hearing loss.
Pathophysiology[edit | edit source]
Tympanosclerosis occurs when there is a deposition of hyaline and calcified plaques in the tympanic membrane and the middle ear. This process is thought to be a result of chronic inflammation, often following repeated episodes of otitis media. The calcification can lead to stiffening of the eardrum and ossicular chain, impairing their ability to transmit sound.
Clinical Presentation[edit | edit source]
Patients with tympanosclerosis may present with symptoms of hearing loss, which is typically conductive in nature. The degree of hearing loss can vary depending on the extent of the calcification and involvement of the ossicular chain. Some patients may also experience tinnitus or a sensation of fullness in the ear.
Diagnosis[edit | edit source]
Diagnosis of tympanosclerosis is primarily clinical, based on otoscopic examination. The eardrum may appear thickened and opaque, with visible white plaques. Audiometry can be used to assess the degree of hearing loss and to differentiate between conductive and sensorineural components.
Treatment[edit | edit source]
Treatment of tympanosclerosis is generally conservative, focusing on managing symptoms. Hearing aids may be used to improve hearing in patients with significant conductive hearing loss. In some cases, surgical intervention, such as tympanoplasty or ossicular chain reconstruction, may be considered to improve hearing.
Prognosis[edit | edit source]
The prognosis for patients with tympanosclerosis varies. While the condition itself is not progressive, the associated hearing loss can impact quality of life. Early intervention and management can help mitigate the effects on hearing.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
